Physician profile
Grady L Bryant
NPI 1134163694
$73,610.90
in general payments reported to CMS, 2019-2025
30 companies · $1,298 in 2025
The $1,298 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $12K · 2021: $370 · 2022: $953 · 2023: $1,941 · 2024: $1,032 · 2025: $1,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,220 · Travel and Lodging: $1,018 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,219.70 |
| Travel and Lodging | $1,018.30 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $67,628.45 | 2019-2025 | Scopis Ent, Xpress Ent Dilation System |
| Medical Device Business Services, INC. | $1,018.30 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $630.74 | 2019-2025 | Dupixent |
| Acclarent, INC | $560.55 | 2021-2024 | Trudi Nav Cable, Acclarent Aera, Acclarent Navwire |
| Genzyme Corporation | $542.65 | 2019-2025 | |
| Glaxosmithkline, LLC. | $519.18 | 2019-2025 | Nucala |
| Aerin Medical INC. | $517.13 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $393.88 | 2019-2025 | |
| Genentech USA, INC. | $299.42 | 2019-2023 | Xolair |
| Smith+Nephew, INC. | $260.46 | 2019-2025 | Tula, Coblation, Halo |
| Integra Lifesciences Corporation | $203.12 | 2022-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Kaleo, INC. | $168.20 | 2019-2024 | Auvi-Q |
| Optinose US, INC. | $164.57 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $145.25 | 2019-2025 | Tezspire, Airsupra |
| Intersect Ent, INC. | $101.60 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $87.65 | 2023-2025 | Inspire |
| Ars Pharmaceuticals Operations, INC. | $69.19 | 2025 | Neffy |
| Medtronic, INC. | $44.15 | 2021-2024 | Propel |
| Alk-Abello, INC | $38.80 | 2019-2025 | Alternaria Tenuis, Pre-Pen, Standardized Mite D. Farinae |
| Amgen INC. | $34.00 | 2025 | |
| Neurent Medical Limited | $24.26 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Hologic Sales and Service, LLC | $21.40 | 2023 | Coolseal Generator |
| Gyrus Acmi, INC. | $21.18 | 2019 | |
| Phadia US INC. | $20.11 | 2024 | Immunocap |
| Paratek Pharmaceuticals, INC. | $19.39 | 2025 | Nuzyra |
| Baxter Healthcare | $19.26 | 2025 | Perclot |
| Olympus America INC. | $16.21 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.35 | 2023 | Seglentis |
| Hikma Pharmaceuticals USA | $13.79 | 2025 | Ryaltris |
| Arbor Pharmaceuticals, INC. | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grady Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.